Drug interactions
Alogliptin-pioglitazone + Fosaprepitant
Severity: Minor
Alogliptin-pioglitazone and Fosaprepitant: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Aprepitant, the active form of fosaprepitant, is a moderate CYP3A4 inhibitor, but a single dose is unlikely to meaningfully change pioglitazone exposure.
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to see why Alogliptin-pioglitazone and Fosaprepitant interact, what to do about it, and the sources.
- Mechanism of action
- Clinical management
- Evidence level
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Alogliptin-pioglitazone
Other interactions of Fosaprepitant
- Alprazolam + Fosaprepitant Moderate
Drug class
- Alogliptin-pioglitazone
- Endocrine
- Fosaprepitant
- Gastrointestinal Tract
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
